Moreover, GIT1 was shown to promote EMT in HCC cells by activating ERK1/2 signaling, but the underlying mechanisms by which GIT1 affect ERK1/2 activation has not been established. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.